CIK 0000315545 · Non-accelerated filer<br>Smaller reporting company
PROVECTUS BIOPHARMACEUTICALS, INC.
Sign in to watch- Ticker
- PVCT
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 900031917
- Phone
- (866) 594-5999
- Business address
- 800 S. GAY STREET, SUITE 1610, KNOXVILLE, TN, 37929
- Former names
- PROVECTUS PHARMACEUTICALS INC, PROVECTUS PHARMACEUTICAL INC, ZAMAGE DIGITAL IMAGING INC, SPM GROUP INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-11-22 | Pershing Edward CEO | Purchase · Series D-1 Convertible Preferred Stock | +80,365 | $2.86 | $230K | 1,691,704 |
| 2024-10-16 | Pershing Edward CEO | Grant or award · 8% Unsecured Convertible Promissory Note | +0 | |||
| 2024-09-30 | Pershing Edward CEO | Grant or award · 8% Unsecured Convertible Promissory Note | +0 | |||
| 2024-09-30 | Lacey John III Director | Grant or award · Series D-1 Convertible Preferred Stock | +179,592 | 179,592 | ||
| 2024-09-30 | Bailey Webster Director | Grant or award · Series D-1 Convertible Preferred Stock | +117,295 | 158,618 | ||
| 2024-09-30 | Rodrigues Dominic PRESIDENT | Grant or award · Series D-1 Convertible Preferred Stock | +196,250 | 1,337,876 | ||
| 2024-09-30 | Pershing Edward CEO | Grant or award · Series D-1 Convertible Preferred Stock | +168,367 | 1,611,339 | ||
| 2024-09-19 | Pershing Edward CEO | Grant or award · 8% Unsecured Convertible Promissory Note | +0 | |||
| 2024-08-29 | Pershing Edward CEO | Grant or award · 8% Unsecured Convertible Promissory Note | +0 | |||
| 2024-08-22 | Pershing Edward CEO | Grant or award · 8% Unsecured Convertible Promissory Note | +0 | |||
| 2024-08-12 | Morris Jeffrey Allen 10% owner | Conversion | +264,314 | $2.86 | $756K | 4,260,061 |
| 2024-08-08 | Pershing Edward CEO | Grant or award · 8% Unsecured Convertible Promissory Note | +0 | |||
| 2024-08-03 | Pershing Edward CEO | Option exercise · 8% Unsecured Convertible Promissory Note | −0 | |||
| 2024-08-03 | Pershing Edward CEO | Option exercise · Series D-1 Convertible Preferred Stock | +28,320 | 1,442,972 | ||
| 2024-07-20 | Pershing Edward CEO | Option exercise · 8% Unsecured Convertible Promissory Note | −0 | |||
| 2024-07-20 | Pershing Edward CEO | Option exercise · Series D-1 Convertible Preferred Stock | +47,199 | 1,414,652 | ||
| 2024-07-18 | Pershing Edward CEO | Grant or award · 8% Unsecured Convertible Promissory Note | +0 | |||
| 2024-06-30 | Pershing Edward CEO | Option exercise · 8% Unsecured Convertible Promissory Note | −0 | |||
| 2024-06-30 | Pershing Edward CEO | Option exercise · Series D-1 Convertible Preferred Stock | +47,180 | 1,367,453 | ||
| 2024-06-26 | Pershing Edward CEO | Grant or award · 8% Unsecured Convertible Promissory Note | +0 |
Page 7 of 8 · 143 trades